Geode Capital Management, LLC Nuvectis Pharma, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 134,528 shares of NVCT stock, worth $831,383. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,528
Previous 131,657
2.18%
Holding current value
$831,383
Previous $1.1 Million
0.46%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NVCT
# of Institutions
39Shares Held
2.11MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$3.48 Million5.37% of portfolio
-
Black Rock Inc. New York, NY373KShares$2.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA299KShares$1.85 Million0.0% of portfolio
-
Baldwin Brothers LLC154KShares$952,5230.1% of portfolio
-
State Street Corp Boston, MA129KShares$799,5620.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $90.5M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...